Long-term effect of the German Parkinson’s disease multimodal complex treatment: a clinical trial with randomized allocation - Summary - MDSpire

Long-term effect of the German Parkinson’s disease multimodal complex treatment: a clinical trial with randomized allocation

  • By

  • Konstantin G. Heimrich

  • Aline Schönenberg

  • Sarah Mendorf

  • Hannah M. Mühlhammer

  • Ulrike Teschner

  • Thomas Lehmann

  • Stefan Brodoehl

  • Tino Prell

  • June 4, 2026

  • 0 min

Share

Objective:

To assess the long-term effects of Parkinson’s disease Multimodal Complex Treatment (PD-MCT) on motor experiences of daily living and health-related quality of life (HRQoL) six months post-discharge, and to evaluate the impact of treatment duration.

Approach:
    Key Findings:
    • The primary outcome is measured using the MDS-UPDRS II scale.
    • Secondary outcomes include HRQoL assessed by the PDQ-8 questionnaire.
    Interpretation:

    Limitations:
    • The treatment duration could be adjusted for ethical reasons, which may affect the results.
    • The study is limited to a single center, which may impact generalizability.
    Conclusion:

    Sources:

Original Source(s)

Long-term effect of the German Parkinson’s disease multimodal complex treatment: a clinical trial with randomized allocation

  • by Konstantin G. Heimrich, Aline Schönenberg, Sarah Mendorf, Hannah M. Mühlhammer, Ulrike Teschner, Thomas Lehmann, Stefan Brodoehl, Tino Prell

  • June 4, 2026

Related Content

Acupuncture effects on non-motor symptoms of Parkinson’s disease (sleep, mood, and fatigue): a systematic review and meta-analysis

A convergence of global epidemics: diabetes as a modulator of neurodegenerative and neuro-inflammatory disorders

Early neural shift detection using functional magnetic resonance imaging: a pilot study with Parkinson’s disease patients undergoing istradefylline and hybrid assistive limb interventions